These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 26457987)
1. CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway. Wang Q; Tang Y; Yu H; Yin Q; Li M; Shi L; Zhang W; Li D; Li L Mol Carcinog; 2016 Nov; 55(11):1688-1699. PubMed ID: 26457987 [TBL] [Abstract][Full Text] [Related]
2. [Study of growth, invasion and metastasis on ovarian epithelial cancer cell line with CCL18 over-expression by mediated in vitro]. Zhang W; Yang YZ; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):528-31. PubMed ID: 24284226 [TBL] [Abstract][Full Text] [Related]
3. Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma. Wang H; Liang X; Li M; Tao X; Tai S; Fan Z; Wang Z; Cheng B; Xia J Cancer Sci; 2017 Aug; 108(8):1584-1593. PubMed ID: 28574664 [TBL] [Abstract][Full Text] [Related]
4. CC Chemokine Ligand 18 Promotes Cell Proliferation and Metastasis of Urothelial Carcinoma via Activating PI3K/mTOR Signaling in Patient with Renal Transplantation. Bo S; Donghao S; Guangqi K; Ye T Urol Int; 2018; 101(4):450-458. PubMed ID: 30189425 [TBL] [Abstract][Full Text] [Related]
5. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway. Dai C; Xie Y; Zhuang X; Yuan Z Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226 [TBL] [Abstract][Full Text] [Related]
6. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway. Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014 [TBL] [Abstract][Full Text] [Related]
7. Nir1 promotes invasion of breast cancer cells by binding to chemokine (C-C motif) ligand 18 through the PI3K/Akt/GSK3β/Snail signalling pathway. Zhang B; Yin C; Li H; Shi L; Liu N; Sun Y; Lu S; Liu Y; Sun L; Li X; Chen W; Qi Y Eur J Cancer; 2013 Dec; 49(18):3900-13. PubMed ID: 24001613 [TBL] [Abstract][Full Text] [Related]
8. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway. Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093 [TBL] [Abstract][Full Text] [Related]
9. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines. Bai H; Li H; Li W; Gui T; Yang J; Cao D; Shen K Oncotarget; 2015 Sep; 6(28):25520-32. PubMed ID: 26267321 [TBL] [Abstract][Full Text] [Related]
10. CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling. Lane D; Matte I; Laplante C; Garde-Granger P; Carignan A; Bessette P; Rancourt C; Piché A Mol Cancer; 2016 Sep; 15(1):58. PubMed ID: 27613122 [TBL] [Abstract][Full Text] [Related]
11. Lactate activates CCL18 expression via H3K18 lactylation in macrophages to promote tumorigenesis of ovarian cancer. Sun J; Feng Q; He Y; Wang M; Wu Y Acta Biochim Biophys Sin (Shanghai); 2024 Jul; 56(9):1373-1386. PubMed ID: 39010846 [TBL] [Abstract][Full Text] [Related]
12. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2. Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281 [TBL] [Abstract][Full Text] [Related]
13. CCL18 promotes the metastasis of squamous cell carcinoma of the head and neck through MTDH-NF-κB signalling pathway. Qin Y; Wang J; Zhu G; Li G; Tan H; Chen C; Pi L; She L; Chen X; Wei M; Li Z; Liu Z; Huang D; Liu Y; Zhang X J Cell Mol Med; 2019 Apr; 23(4):2689-2701. PubMed ID: 30768878 [TBL] [Abstract][Full Text] [Related]
14. DHA inhibits invasion and metastasis in NSCLC cells by interfering with CCL18/STAT3 signaling pathway. Luo HQ; Huang YM; Li J; Tang XD; Chen R; Wang Y; Ren J; Dai QQ; Lan LB; Chen JY; Li XY Clin Exp Med; 2023 Oct; 23(6):2311-2320. PubMed ID: 36217054 [TBL] [Abstract][Full Text] [Related]
15. Macrophage ERα promoted invasion of endometrial cancer cell by mTOR/KIF5B-mediated epithelial to mesenchymal transition. Jing X; Peng J; Dou Y; Sun J; Ma C; Wang Q; Zhang L; Luo X; Kong B; Zhang Y; Wang L; Qu X Immunol Cell Biol; 2019 Jul; 97(6):563-576. PubMed ID: 30779215 [TBL] [Abstract][Full Text] [Related]
16. Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism. Ma Z; Zhang T; Wang R; Cheng Z; Xu H; Li W; Wang Y; Wang X Int J Gynecol Cancer; 2011 May; 21(4):616-24. PubMed ID: 21543928 [TBL] [Abstract][Full Text] [Related]
17. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study. Yu X; Zhang Y; Chen H BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800 [TBL] [Abstract][Full Text] [Related]
18. CC chemokine ligand 18(CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway. Shi L; Zhang B; Sun X; Zhang X; Lv S; Li H; Wang X; Zhao C; Zhang H; Xie X; Wang Y; Zhang P Mol Carcinog; 2016 Dec; 55(12):2051-2062. PubMed ID: 26756176 [TBL] [Abstract][Full Text] [Related]
19. CCL18-induced HOTAIR upregulation promotes malignant progression in esophageal squamous cell carcinoma through the miR-130a-5p-ZEB1 axis. Wang W; Wu D; He X; Hu X; Hu C; Shen Z; Lin J; Pan Z; He Z; Lin H; Wang M Cancer Lett; 2019 Sep; 460():18-28. PubMed ID: 31207321 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA RP11-552M11.4 promotes cells proliferation, migration and invasion by targeting BRCA2 in ovarian cancer. Huang K; Geng J; Wang J Cancer Sci; 2018 May; 109(5):1428-1446. PubMed ID: 29478268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]